Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment
Clinical trial NCT07007962 · RECRUITING
Trial details
- NCT number
- NCT07007962
- Sponsor
- Sanofi
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-24
- Primary completion
- 2027-11-05
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.